المؤلفون: Puzanov, I, Diab, A, Abdallah, K, Bingham, CO, Brogdon, C, Dadu, R, Hamad, L, Kim, S, Lacouture, ME, LeBoeuf, NR, Lenihan, D, Onofrei, C, Shannon, V, Sharma, R, Silk, AW, Skondra, D, Suarez-Almazor, ME, Wang, Y, Wiley, K, Kaufman, HL, Ernstoff, MS, on behalf of the Society for Immunotherapy of Cancer Toxicity Management Working Group

المصدر: Journal for ImmunoTherapy of Cancer. 5(1)

مصطلحات موضوعية: Lung, Cancer, Patient Safety, Immunization, 7.3 Management and decision making, Management of diseases and conditions, Development of treatments and therapeutic interventions, 5.1 Pharmaceuticals, Good Health and Well Being, Clinical Decision-Making, Evidence-Based Medicine, Humans, Immunotherapy, Neoplasms, Neurotoxicity Syndromes, Practice Guidelines as Topic, Societies, Medical, Immune-related adverse events, Toxicity, Immune checkpoint inhibitor, Society for Immunotherapy of Cancer Toxicity Management Working Group

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/9072j145

المؤلفون: Akaike T; University of Washington, Seattle, WA., Thakuria M; Brigham and Women's Hospital, Boston, MA.; Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Silk AW; Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Hippe DS; Fred Hutchinson Cancer Center, Seattle, WA., Park SY; University of Washington, Seattle, WA., So NA; Stanford University School of Medicine, Palo Alto, CA., Maloney NJ; Stanford University School of Medicine, Palo Alto, CA., Gunnell L; University of Washington, Seattle, WA., Eschholz A; Stanford University School of Medicine, Palo Alto, CA., Kim EY; Brigham and Women's Hospital, Boston, MA., Sinha S; University of California San Francisco, San Francisco, CA., Hall ET; University of Washington, Seattle, WA., Bhatia S; University of Washington, Seattle, WA., Reddy S; Stanford University School of Medicine, Palo Alto, CA., Rodriguez AA; Natera, Inc, Austin, TX., Aleshin A; Natera, Inc, Austin, TX., Choi JS; Northwestern University, Chicago, IL., Tsai KY; Moffitt Cancer Center, Tampa, FL., Yom SS; University of California San Francisco, San Francisco, CA., Yu SS; University of California San Francisco, San Francisco, CA., Choi J; Northwestern University, Chicago, IL., Chandra S; Northwestern University, Chicago, IL., Nghiem P; University of Washington, Seattle, WA., Zaba LC; Stanford University School of Medicine, Palo Alto, CA.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Sep 10; Vol. 42 (26), pp. 3151-3161. Date of Electronic Publication: 2024 Jul 25.

نوع المنشور: Journal Article; Multicenter Study; Observational Study

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Merkel Cell*/blood , Carcinoma, Merkel Cell*/genetics , Carcinoma, Merkel Cell*/pathology , Circulating Tumor DNA*/blood , Circulating Tumor DNA*/genetics , Neoplasm Recurrence, Local*/genetics , Neoplasm Recurrence, Local*/blood , Neoplasm Recurrence, Local*/diagnosis , Skin Neoplasms*/blood , Skin Neoplasms*/genetics , Skin Neoplasms*/pathology , Skin Neoplasms*/diagnosis , Disease Progression* , Neoplasm, Residual*, Humans ; Male ; Female ; Aged ; Prospective Studies ; Middle Aged ; Prognosis ; Aged, 80 and over ; Biomarkers, Tumor/blood ; Biomarkers, Tumor/genetics ; Adult

المؤلفون: Hughes BGM; Department of Cancer Care Services, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia. Electronic address: brett.hughes@health.qld.gov.au., Guminski A; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, New South Wales, Australia., Bowyer S; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia., Migden MR; Departments of Dermatology and Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Schmults CD; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Khushalani NI; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA., Chang ALS; Department of Dermatology, Stanford University School of Medicine, Redwood City, CA, USA., Grob JJ; Aix Marseille University, Hôpital de la Timone, Marseille, France., Lewis KD; University of Colorado Denver Cancer Center, Aurora, CO, USA., Ansstas G; Department of Surgical Oncology, Washington University School of Medicine, St Louis, MO, USA., Day F; Department of Medical Oncology, Calvary Mater Newcastle, Newcastle, New South Wales, Australia., Ladwa R; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, New South Wales, Australia; Princess Alexandra Hospital, Woolloongabba, Queensland, Australia., Stein BN; Adelaide Cancer Centre, Adelaide, South Australia, Australia., Muñoz Couselo E; Department of Medical Oncology, Melanoma and Other Skin Tumors Unit, Vall d'Hebron University Hospital, Barcelona, Spain., Meier F; Department of Dermatology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Skin Cancer Center at the University Cancer Centre and National Center for Tumor Diseases, Dresden, Germany., Hauschild A; Department of Dermatology, University Hospital (UKSH), Kiel, Germany., Schadendorf D; Department of Dermatology, University Hospital of Essen, Essen, Germany; German Cancer Consortium, Partner Site Essen, NCT-West, Campus Essen and University Alliance Ruhr, Research Center One Health, University Duisburg-Essen, Essen, Germany., Basset-Seguin N; Hôpital Saint-Louis, Paris, France., Modi B; Department of Surgery, Division of Dermatology, City of Hope, Duarte, CA, USA., Dalac-Rat S; Hospital Center University Dijon Bourgogne, Dijon, France., Dunn LA; David H. Koch Center for Cancer Care, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Flatz L; University Hospital Tübingen, Tübingen, Germany., Mortier L; Centre Hospitalier Régional Universitaire de Lille (CHRU), Lille, France., Guégan S; Department of Dermatology, Hôpital Cochin, Paris, France., Heinzerling LM; Department of Dermatology, LMU University Hospital Munich, Munich, Germany; Department of Dermatology, University Hospital Erlangen, Erlangen, Germany., Mehnert JM; Melanoma and Cutaneous Medical Oncology, Perlmutter Cancer Center, NY University, Langone Health, New York, NY, USA., Trabelsi S; CHU de Grenoble - Hôpital A Michallon, Grenoble, France., Soria-Rivas A; Ramón y Cajal University Hospital, Spanish Society of Medical Oncology (SEOM), Madrid, Spain., Stratigos AJ; First Department of Dermatology-Venereology, Andreas Sygros Hospital, Athens, Greece; National and Kapodistrian University of Athens Medical School, Athens, Greece., Ulrich C; Charite-Universitatsmedizin Berlin, Berlin, Germany., Wong DJ; UCLA Department of Medicine, Los Angeles, CA, USA., Beylot-Barry M; Department of Dermatology, University Hospital of Bordeaux, Bordeaux, France., Bossi P; Department of Biomedical Sciences, Humanitas University, Milan, Italy; IRCCS Humanitas Research Hospital, Milan, Italy., Bugés Sánchez C; Department of Medical Oncology, Skin Tumors Unit, Catalan Institute of Oncology, Germans Trias i Pujol University Hospital, Barcelona, Spain; Badalona-Applied Research Group in Oncology (B-ARGO), Badalona, Barcelona, Spain., Chandra S; Division of Hematology Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Robert C; Gustave Roussy Cancer Center, Villejuif, France., Russell JS; Head and Neck/Cutaneous Medical Oncology, Huntsman Cancer Institute, Salt Lake City, UT, USA., Silk AW; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Booth J; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Yoo SY; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Seebach F; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Lowy I; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Fury MG; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Rischin D; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

المصدر: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Sep 06. Date of Electronic Publication: 2024 Sep 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE

المؤلفون: Khaddour K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Harvard Medical School, Boston, MA 02115, USA., Murakami N; Harvard Medical School, Boston, MA 02115, USA.; Division of Renal Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA., Ruiz ES; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Harvard Medical School, Boston, MA 02115, USA.; Department of Dermatology, Brigham and Women's Hospital, Boston, MA 02115, USA., Silk AW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Center for Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Harvard Medical School, Boston, MA 02115, USA.

المصدر: Cancers [Cancers (Basel)] 2024 Sep 04; Vol. 16 (17). Date of Electronic Publication: 2024 Sep 04.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Ruiz ES; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts., Silk AW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Sethi RK; Department of Otolaryngology, Brigham and Women's Hospital, Boston, Massachusetts.

المصدر: JAMA otolaryngology-- head & neck surgery [JAMA Otolaryngol Head Neck Surg] 2024 Sep 01; Vol. 150 (9), pp. 832-833.

نوع المنشور: Journal Article; Case Reports

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589542 Publication Model: Print Cited Medium: Internet ISSN: 2168-619X (Electronic) Linking ISSN: 21686181 NLM ISO Abbreviation: JAMA Otolaryngol Head Neck Surg Subsets: MEDLINE

مواضيع طبية MeSH: Skin Neoplasms*/diagnosis , Skin Neoplasms*/pathology , Carcinoma, Squamous Cell*/diagnosis , Carcinoma, Squamous Cell*/pathology , Head and Neck Neoplasms*/diagnosis , Head and Neck Neoplasms*/pathology, Humans ; Diagnosis, Differential ; Squamous Cell Carcinoma of Head and Neck/diagnosis ; Squamous Cell Carcinoma of Head and Neck/pathology ; Male

المؤلفون: Maloney AK; Quinnipiac University Frank H Netter MD School of Medicine, North Haven, Connecticut, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Giobbie-Hurder A; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Katukota N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Fogarasi MC; Quinnipiac University Frank H Netter MD School of Medicine, North Haven, Connecticut, USA., Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Sussman TA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Silk AW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Haq R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Liu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Insco M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Buchbinder EI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA elizabeth_buchbinder@dfci.harvard.edu.; Harvard Medical School, Boston, Massachusetts, USA.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Aug 28; Vol. 12 (8). Date of Electronic Publication: 2024 Aug 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Nivolumab*/therapeutic use , Nivolumab*/adverse effects , Nivolumab*/pharmacology , Nivolumab*/administration & dosage , Ipilimumab*/therapeutic use , Ipilimumab*/adverse effects , Ipilimumab*/pharmacology , Ipilimumab*/administration & dosage , Melanoma*/drug therapy , Melanoma*/mortality, Humans ; Male ; Female ; Retrospective Studies ; Middle Aged ; Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Adult ; Aged, 80 and over

المؤلفون: Little JS; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Hurtado RM; Harvard Medical School, Boston, Massachusetts, USA.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA., Boire N; Harvard Medical School, Boston, Massachusetts, USA.; Division of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Baden LR; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Laga AC; Harvard Medical School, Boston, Massachusetts, USA.; Division of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Silk AW; Harvard Medical School, Boston, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Jacobson CA; Harvard Medical School, Boston, Massachusetts, USA.; Stem Cell Transplant and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

المصدر: Open forum infectious diseases [Open Forum Infect Dis] 2024 Aug 08; Vol. 11 (9), pp. ofae460. Date of Electronic Publication: 2024 Aug 08 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE

المؤلفون: Liu KX; Department of Radiation Oncology, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Shin KY; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Thakuria M; Merkel Cell Carcinoma Center of Excellence, Dana-Farber/Brigham & Women's Cancer Center, Boston, Massachusetts, USA.; Department of Dermatology, Brigham & Women's Hospital, Boston, Massachusetts, USA., Schoenfeld JD; Department of Radiation Oncology, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Merkel Cell Carcinoma Center of Excellence, Dana-Farber/Brigham & Women's Cancer Center, Boston, Massachusetts, USA., Tishler RB; Department of Radiation Oncology, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Merkel Cell Carcinoma Center of Excellence, Dana-Farber/Brigham & Women's Cancer Center, Boston, Massachusetts, USA., Silk AW; Merkel Cell Carcinoma Center of Excellence, Dana-Farber/Brigham & Women's Cancer Center, Boston, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Yoon CH; Merkel Cell Carcinoma Center of Excellence, Dana-Farber/Brigham & Women's Cancer Center, Boston, Massachusetts, USA.; Division of Surgical Oncology, Department of Surgery, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA., Fite E; Department of Radiation Oncology, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Margalit DN; Department of Radiation Oncology, Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Merkel Cell Carcinoma Center of Excellence, Dana-Farber/Brigham & Women's Cancer Center, Boston, Massachusetts, USA.

المصدر: Cancer [Cancer] 2024 Aug 05. Date of Electronic Publication: 2024 Aug 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

المؤلفون: Miller DM; Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Shalhout SZ; Harvard Medical School, Boston, Massachusetts, USA.; Mike Toth Head and Neck Cancer Research Center, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.; Department of Otolaryngology, Head and Neck Surgery, Division of Surgical Oncology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA., Wright KM; Mike Toth Head and Neck Cancer Research Center, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA., Miller MA; Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA., Kaufman HL; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA., Emerick KS; Harvard Medical School, Boston, Massachusetts, USA.; Department of Otolaryngology, Head and Neck Surgery, Division of Surgical Oncology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA., Reeder HT; Harvard Medical School, Boston, Massachusetts, USA.; Biostatistics, Massachusetts General Hospital, Boston, Massachusetts, USA., Silk AW; Harvard Medical School, Boston, Massachusetts, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Thakuria M; Harvard Medical School, Boston, Massachusetts, USA.; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, USA.

المصدر: Cancer [Cancer] 2024 Aug 01; Vol. 130 (15), pp. 2670-2682. Date of Electronic Publication: 2024 May 02.

نوع المنشور: Journal Article; Observational Study; Multicenter Study

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Merkel Cell*/virology , Carcinoma, Merkel Cell*/blood , Carcinoma, Merkel Cell*/mortality , Carcinoma, Merkel Cell*/diagnosis , Carcinoma, Merkel Cell*/immunology , Merkel cell polyomavirus*/immunology , Merkel cell polyomavirus*/isolation & purification , Skin Neoplasms*/blood , Skin Neoplasms*/virology , Skin Neoplasms*/mortality , Skin Neoplasms*/diagnosis , Skin Neoplasms*/immunology , Skin Neoplasms*/pathology , Antibodies, Viral*/blood, Humans ; Female ; Male ; Retrospective Studies ; Aged ; Prognosis ; Middle Aged ; Aged, 80 and over ; Tumor Virus Infections/virology ; Polyomavirus Infections/blood ; Polyomavirus Infections/diagnosis ; Polyomavirus Infections/virology ; Polyomavirus Infections/immunology

المؤلفون: Emens LA; Ankyra Therapeutics, Cambridge, Massachusetts, USA emensle@icloud.com jwargo@mdanderson.org., Romero PJ; Novigenix, Epalinges, Switzerland., Anderson AC; The Gene Lay Institute of Immunology and Inflammation, Ann Romney Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, USA., Bruno TC; Department of Immunology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Capitini CM; Department of Pediatrics and Carbone Cancer Center, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA., Collyar D; Patient Advocates in Research (PAIR), Danville, California, USA., Gulley JL; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Hwu P; Moffitt Cancer Center, Tampa, Florida, USA., Posey AD Jr; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Silk AW; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA emensle@icloud.com jwargo@mdanderson.org.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Jun 19; Vol. 12 (6). Date of Electronic Publication: 2024 Jun 19.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy*/methods , Neoplasms*/therapy , Neoplasms*/immunology, Humans ; Societies, Medical